Skip Navigation

Publications

Ackley R, Roshdy D, Meredith J, Minor S, Anderson W, Capraro J, Polk C.  Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections. Antimicrobial Agents and Chemotherapy Feb 2020, AAC.02313-19

Roshdy D, Jaffa R, Pillinger KE, Rozario N, Guffey J, Davidson L, McCurdy L. Effect of a multifaceted stewardship intervention of antibiotic prescribing and outcomes for acute bacterial skin and skin structure infections. Ther Adv Infect Dis 2018;5(6):103-109.

Roshdy D, Pillinger KE, Jaffa R, Pasquale TR. C. difficile lives up to its name – The need for systematic approaches for treatment and prevention of future recurrence. Infect Dis Clin Prac 2018;26(2):57-59.

Martin KE, Roshdy D, Kasbekar R, Pasquale TR. Use of risk stratification tools to enhance antimicrobial stewardship practices. Infect Dis Clin Prac 2016;24:204-9.

Meredith J, Onsrud J, Davidson L, Medaris L, Kowalkowski M, Fischer K, Priem J, Leonard M, McCurdy L, Successful Use of Telemedicine Infectious Diseases Consultation with an Antimicrobial Stewardship-Led Staphylococcus aureus Bacteremia Care Bundle, Open Forum Infectious Diseases, 2021;, ofab229, https://doi.org/10.1093/ofid/ofab229

Jaffa RK, Pillinger KE, Roshdy D, Isip JA, Pasquale TR. Novel developments in the treatment of acute bacterial skin and skin structure infections. Expert Opin Pharmacother. 2019 May 30:1-10. 

Barnes E, Zhao J, Giumenta A, Johnson M. The effect of an integrated health system specialty pharmacy on HIV antiretroviral therapy adherence, viral suppression, and CD4 count in an outpatient infectious diseases clinic. J Manag Care Spec Pharm 2020;26(2):95-102.

Nimmich EB, Bookstaver PB, Kohn J, Justo JA, Hammer KL, Albrecht H, Al-Hasan MN. Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence. Hosp Pharm 2017; 52(10):691-697.

Bookstaver PB, Nimmich EB, Smith TJ 3rd, Justo JA, Kohn J, Hammer KL, Troficanto C, Albrecht HA, Al-Hasan MN. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections. Antimicrobial Agents and Chemotherapy 2017; 61(9).

Speight CC, Williamson JE, Ebied AM, Medaris LA, McCurdy L, Hammer KL.  Impact of Infectious Diseases Consultation in Patients With Candidemia at a Multisite Health Care System With Established Antimicrobial Stewardship and Telemedicine Services. Open Forum Infect Dis. 2023 Jul 20;10(8):ofad388. doi: 10.1093/ofid/ofad388. eCollection 2023 Aug. PMID: 37555131

Roshdy D, McCarter M, Meredith J, Jaffa R, Hammer K, Santevecchi B, Rozario N, Campbell J, Leonard M, Polk C.  Implementation of a comprehensive intervention focused on hospitalized patients with HIV by an existing stewardship program: successes and lessons learned. Ther Adv Infect Dis. 2021 Apr 19;8:20499361211010590. doi: 10.1177/20499361211010590. eCollection 2021 Jan-Dec. PMID: 33953916

Hammer KL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan, M. Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease 2017; 1(87):87-91.

Hammer KL, Stoessel A, Justo JA, Bookstaver PB, Kohn J, Derrick CB, et al. Association between chronic hemodialysis and bloodstream infections due to chromosomally mediated AmpC-producing EnterobacteriaceaeAm J Infect Control 2016; 12(44):1611-16.

DeVaul KL, Sutton S, Steadman S, Rowen RC. Chapter 20. Upper Respiratory Tract Infections. In: Sutton S. 2nd eds. McGraw-Hill's NAPLEX Review Guide. New York, NY: McGraw-Hill; 2014.

DeVaul KL. Bug Bites, Bleeding and Biologic Preventative Methods: Emerging Pathogens. Making a Difference in Infectious Diseases Pharmacotherapy. 2013; 3(3):6-12.

Jaffa RK, Hammer J, Medaris LA, Anderson WE, et al.  Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock.  Am J Emerg Med 2021;48: 255-60

Kasbekar R, Maples M, Bernacchi A, Duong L, Oramasionwu CU. The pharmacist’s role in preventing medication errors in older adults. Consult Pharm.2014; 29 (12): 833-837.

Kovacik CN, Shah MD, Thomas TA, Eby JC. First-Dose Antimicrobial Infusion Reactions in Patients Enrolled in Outpatient Parenteral Antimicrobial Therapy Services. Open Forum Infect Dis. 2023; 10(6): ofad239.

Gandhi AM, Shah MD, Donohue LE, Cox HL, Eby JC. Tolerability of cefazolin in nafcillin-intolerant patients for the treatment of methicillin-susceptible Staphylococcus aureus infections. Clin Infect Dis. 2021;73(9): 1650-1655.

Robinson ED, Stilwell A, Attai AE, Donohue LE, Shah MD, Hill BK, Elliott ZS, Poulter M, Brewster F, Cox HL, Mathers AJ. Implementation of a rapid phenotypic susceptibility platform for Gram-negative bloodstream infections with paired antimicrobial stewardship intervention: is the juice worth the squeeze? Clin Infect Dis. 2021;71(5): 783-792.

Shah MD, Balada-Llasat JM, Coe K, Reed E, Sandlund J, Pancholi P. Evaluation of cycle threshold, toxin concentration, and clinical characteristics of Clostridioides difficile infection in patients with discordant diagnostic test results. J Clin Microbiol. 2020;58(5): e01681-19.

Shah MD, Coe KE, El Boghdadly Z, Wardlow LC, Dela-Pena JC, Stevenson KB, Reed EE. Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia. J Antimicrob Chemother. 2019;74(7): 2055-2059.

Shah MD, Wardlow LC, Stevenson KB, Coe KE, Reed EE. Clinical outcomes with penicillin versus alternative β-Lactams in the treatment of penicillin-susceptible Staphylococcus aureus bacteremia. Pharmacotherapy. 2018;38(7): 769-775.

Schweiger JA, Phillips K, Patel A, Echols C. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood & Cancer. 2022;69(2):e29379. doi:10.1002/pbc.29379

Schweiger JA, Carpenter DM, Thomas KC, Garcia N, Adjei A, Lee C, Tudor G, Sleath B. Development of a video intervention to motivate teens to ask providers questions about ADHD. Cogent psychology. 2023;10(1). doi: 10.1080/23311908.2023.2278364 

Welch SN, Patel RM, Morris LE, et al. Impact of antimicrobial stewardship and rapid diagnostics in children with Staphylococcus aureus bacteremia. J Am Coll Clin Pharm. 2020;1-8. doi:10.1002/jac5.1304.

Petteys MM, Medaris LA, Williamson JE, et al. Outcomes and antibiotic use in patients with coronavirus disease 2019 (COVID-19) admitted to an intensive care unit. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e12. Published 2022 Jan 17. doi:10.1017/ash.2021.248

Petteys MM, Kachur E, Pillinger KE, He J, Copelan EA, Shahid Z. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin. J Oncol Pharm Pract. 2020;26(3):632-640. doi:10.1177/1078155219865303

Rausch E, Vemuri K, Anderman T, Daniels L, Fabricio J, Lachiewicz, Marx A, Sena AC, VanDuin D, Bartelt L. Eravacycline associated hypofibronogenemia: a case series of transplant patients with Mycobacterium abscessus infections and review of literature. Open Forum Infect Dis. 2022. PMID 36570967 

Marx AH, Cluck D, Green SB, Anderson DT, Stover KR, Chastain DB, Covington EW, Jones BM, Lantz E, Rausch E, Tu P, Wagner JL, White C, Bookstaver PB, Bland CM.  A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications for Hospitalized Patients in 2021. Open Forum Infect Dis. 2022. PMID 36519115 

Oral Abstracts

Logan AY, Williamson JE, Jarrett S, and Davidson L. Made to measure:  development of a scoring tool to customize antimicrobial stewardship goals across a large health-system. Oral Abstract Presentation presented at ID Week, San Francisco, CA; Oct 2018.

Welch S, Patel R, Morris L, Dassner A, Rozario N, Forrester J. Clinical Impact of Antimicrobial Stewardship and Rapid Diagnostics in Children with Staphylococcus aureus Bacteremia. Oral Abstract Presentation presented at ID Week, Washington, D.C; Oct 2019.

Ackley R, Roshdy D, Meredith J, Minor S, Anderson WE, Capraro GA, Polk C. Recurrence of Infection and Emergence of Drug Resistance After Treatment with Meropenem/Vaborbactam Compared to Ceftazidime/Avibactam in Carbapenem-Resistant Enterobacteriaceae Infections. Oral platform and poster presented at IDWeek 2019,Washington, D.C. 

Hammer K, Shifflet A, Petteys M, Soman R, Williamson JE, Medaris LA, and Shahid Z. Impact of infectious diseases consultation in patients with candidemia at a large multi-site healthcare system providing telemedicine services. Oral Abstract Presentation presented at ID Week, Virtual; Oct 2021.

Shields RKAbbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Cifuentes R, Claeys KC, DeSear K, Gallagher JG, Gregory E, Heil EL, Hickey C, Klatt M, Kline EG, Kubat RC, Kufel WD, Lee JH, Lim A, Lingg T, MacDougall C, Mathers A, McCreary EK, Moore WJ, Olson S, Oxer J, Pham C, Polk C, Satlin MJ, Satola SW, Shah S, Solanki YB, Tamma PD, Vega A, Venugopalan V, Veve M, Wangchinda W, Witt LS, Wu J, Pogue JM. A multicenter, observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS). Oral platform presented at IDWeek 2023, Boston, MA. 

Poster Abstracts

Vanderburg H, Meredith J, Jaffa R, Aviles C, Motz B, Vrochides D, Medaris L. “Impact of an Antibiotic Stewardship Treatment and Management Algorithm for Liver Abscesses.” Anticipated poster presentation, to be presented at IDWeek 2021 Virtual Conference. October 2021

Lefemine A, Meredith J, Hammer K, Kachur K, He J, Speight C, Shahid Z. “Risk Factors and Clinical Outcomes in Patients with Hematologic Malignancies and Infections Caused by Extended Spectrum Beta-Lactamase Producing Enterobacterales.” Anticipated poster presentation, to be presented at IDWeek 2021 Virtual Conference. October 2021. 

Wayman M, Meredith J, Welch S, Polk C. “Evaluation of Antimicrobial Prescribing Practice for Vancomycin-Resistant Enterococcus Bacteremia.” Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2020.

Meredith J., Roshdy D., Jaffa R., Medaris L., Aviles C., Cochran A., Fischer K., Sashtry V., Davidson L. “Bridging the Divide Between Antimicrobial Stewardship and Surgical Services: Successful Use of Handshake Stewardship with Hepato-Pancreato-Biliary Surgical Services in Adult Patients at a Large Academic Medical Center.” Poster presentation presented at IDWeek 2020 Virtual Conference. October 2020. 

Welch S., Meredith J., Roshdy D., Medaris L., McCarter M., McCurdy L. “Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia.” Poster presentation presented at IDWeek 2020 Virtual Conference. October 2020.

Green B., Meredith J., Ackley R., McCarter M., Polk C. “Novel Beta-lactam Beta-lactamase Inhibitors Against Alternative Antibiotics for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis Caused by Carbapenem-resistant Enterobacterales.” Poster presentation presented at IDWeek 2020 Virtual Conference. October 2020.

Ackley R., Roshdy R., Isip J., Minor S., Elchynski A., Anderson W., Capraro G., Polk C. “Meropenem/vaborbactam versus Ceftazidime/avibactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections.” Poster presented at Poster presented at Making a Difference in Infectious Diseases (MAD-ID). Orlando, FL. May 2019.  

Elchynski A., Ackley R., Roshdy D., Minor S., Isip J., Reyenga, C., Capraro G., Anderson W., Polk C. “Meropenem/vaborbactam versus Ceftazidime/avibactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections.” Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2018.

Isip J., Medaris L., McCurdy, L., Kowalkowski, M., Fischer, K., Onsrud, J., Davidson L. “Successful Use of Telemedicine versus On-site Infectious Diseases Consultation After Implementation of a System-wide Antimicrobial Stewardship-led Staphylococcus aureus Bacteremia Care Bundle.” Poster to be presented at IDWeek 2018. San Francisco, CA. October 2018.

Jaffa R., Onsrud J., Ray J., Boger M., Davidson L., Isip J. “Antimicrobial Stewardship Led Development of a System-Wide Desensitization and Graded Dose Challenge Protocol.” Poster presented at Making a Difference in Infectious Diseases (MAD-ID). Orlando, FL. May 2018.  

Jaffa RK, Ton M, Forrester J, Patel R, Brantley C, Campbell J, Carlson TJ, Davidson L, Patel N, Shah E, Boger S. Validation of an Adult and Pediatric Beta-Lactam Allergy Risk Stratification Tool. IDWeek 2021

Boger MS, Jaffa R, Kiliany R, Shah E, Morris L, Davidson L.  Improving assessment of beta-lactam allergies by embedding a questionnaire in best practice advisory alerts across a large health system.  Poster presentation at: IDWeek 2023; Oct 2023; Boston MA.

Fowler M, Williamson J, Phan J, Jaffa R, Carlson T, Medaris LA.  Outcomes associated with primary antibiotic therapy in spinal epidural abscess due to Staphylococcus aureus: comparison of first-line vs alternative agents.  Poster presentation at: IDWeek 2023; Oct 2023; Boston MA.

Williamson J, Wood S, Jaffa R, Boger M, Carlson T.  Evaluation of continuous versus intermittent infusion of nafcillin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.  Poster presentation at: IDWeek 2023; Oct 2023; Boston MA.

Koons M, Jaffa RK, Roach E, Medaris LA.  System-wide evaluation of the optimal use of ertapenem.  Poster presentation at:American Society of Health-System Pharmacists Midyear Clinical Meeting Virtual Conference; Dec 2021.

Phan J, Jaffa RK, Williamson J, Boger MS.  Evaluation of aztreonam use across a large healthcare system.  Poster presentation at:American Society of Health-System Pharmacists Midyear Clinical Meeting Virtual Conference; Dec 2021.

Jaffa RK, Ton MT, Forrester JB, Patel R, Brantley CW, Campbell J, Carlson TJ, Morris L, Patel NC, Shah E, Davidson L, Boger MS.  Validation of an adult and pediatric beta-lactam allergy risk stratification tool.  Poster presentation at: IDWeek 2021 Virtual Conference; Sept 2021.

Jaffa RK, Williamson JE, Denton G, Davidson L, Boger MS.  Antimicrobial Stewardship Led Development of a System-Wide Desensitization and Graded Dose Challenge Protocol Poster presentation at: Making a Difference in Infectious Diseases Virtual Conference; May 2021.

Jaffa RK, Pillinger KE, Medaris LA, Anderson W, Heffner AC, Hammer JM. Outcomes associated with empiric aztreonam use compared to anti-pseudomonal β-lactams in patients with sepsis: an opportunity for allergy stewardship.  Presented at: IDWeek 2020 Virtual Conference; Oct 2020.

Roshdy D, Ginn T, Jaffa R, Green E, Anderson W, Medaris LA. Fluconazole versus echinocandins as initial therapy for candidemia caused by fluconazole-susceptible species in the era of rapid diagnostic testing. Poster presentation at: IDWeek; Oct 2019; Washington DC.

Roshdy D, Santevecchi B, Isip J, Hammer K, Jaffa RK, Leonard M, Polk C. Impact of a novel infectious diseases pharmacy service on medication-related errors and linkage to care in inpatients living with Human Immunodeficiency Virus.  Poster presentation at: IDWeek; Oct 2019; Washington DC.

Hill H, Shillingburg A, Jaffa RK, Taylor M. Oral ribavirin use for the treatment of viral respiratory infections in immunocompromised patients.  Poster presentation at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2019 Dec; Las Vegas, NV.

Jaffa R, Mably M, Koth S, et al.  Antimicrobial prophylaxis in adult and pediatric hematopoietic stem cell transplant patients: development and implementation of a clinical practice guideline. Poster presentation at the 2016 Vizient University Health System Consortium Pharmacy Nedtwork Meeting; 2016 Dec; Las Vegas, NV.

Phan M, Ackley R, Meredith J, Ebied A, Sampson M. Comparative Use of Vancomycin versus Ampicillin for Blood Stream Infections Caused by Ampicillin-susceptible Enterococcus faecalis. Poster presented at IDWeek 2022, Washington, D.C. 

Schweiger JA, Poole NM, Cotter JM, Ambroggio L, MacBrayne CE. A Clinical Care Pathway Improves Antibiotic Prescribing in Hospitalized Children with Community Acquired Pneumonia. IDWeek 2023.

Hammer KL, Hamm A, Welch SN, Smith JR, Medaris L, Boger MS, Williamson JE.  Does Cefepime Provide an Advantage over Ceftriaxone in the Treatment of Bloodstream Infections due to Escherichia coli, Klebsiella pneumoniae group, Klebsiella oxytoca, and Proteus spp. if CTX-M is not Detected by Rapid Molecular Testing?  Poster presentation at IDWeek 2023; October 2023.

Lefemine A, Meredith J, Patel R, et al. Cidofovir prescribing patterns and outcomes in hospitalized adults and children. Poster presented at: 11th Annual IDWeek Meeting; Oct 21, 2022; Washington, D.C.. 

Lefemine A, Roshdy D, Meredith J, Strassels S, Polk C. Comparison of nafcillin versus cefazolin for the early treatment of methicillin-susceptible Staphylococcus aureus infective endocarditisPoster presented at: 24th Annual MAD-ID Meeting; May 19, 2022; Orlando, FL. 

Lefemine A, Meredith J, Hammer K, et al. Risk factors and clinical outcomes in patients with hematologic malignancies and infections caused by extended-spectrum beta-lactamase-producing Enterobacterales. Poster presented at: 10th Annual IDWeek Meeting; September 29, 2021; Virtual. 

Petteys M, Medaris LA, Williamson JE, Denmeade T, Soman R, Anderson WE, Leonard MK, and Polk CM. Outcomes and antibiotic use in patients with COVID-19 admitted to an intensive care unit. Poster presented at: 10th Annual IDWeek Meeting; September 29, 2021; Virtual. 

Williamson, JE, Logan AY, Jarrett SW, Irausquin SJ, Boger MS, and Davidson LE. If symptoms aren’t described, antibiotics aren’t prescribed:  Implementation of a multifaceted toolkit targeting overtreatment of asymptomatic bacteriuria across a large health-system. Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), San Francisco, CA.

Logan AY, Williamson JE, Reinke EK, Jarrett S, and Davidson LE. Does anyone have the time: feasibility of using an antimicrobial stewardship tool to aid pharmacist assessment of patients with positive urine cultures. Presented at American Society of Health-Systems Pharmacists Annual Midyear Meeting, Orlando, FL

Williamson JE, Logan AY, Reinke EK, Jarrett S, and Davidson LE. Hiding in plain sight:  observations from a review of positive urine cultures prior an antimicrobial stewardship campaign targeting asymptomatic bacteriuria. Presented at ID Week  (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), San Diego, CA

Logan AY, Owens EH, Floyd GG, Gonzalez EG, Reinke EK, Williamson JE, and Davidson LE. Targeting low-hanging fruit:  the impact of a focused antimicrobial stewardship intervention on fluoroquinolone consumption at a community hospital. Presented at Making a Difference In Infectious Disease (MAD-ID) Annual Meeting, Orlando, FL.

Williamson JE, Logan AY, Reinke EK, Jarrett S, Clarke C, and Davidson LE. The first step is always the hardest:  building a framework for stewardship across a large, diverse healthcare system. Presented at ID Week  (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), New Orleans, LA.

Vu BN, Chung P, Williamson JE, and Guo Y. Streamlining daptomycin therapy in an academic medical center. Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), New Orleans, LA.

Vu BN, Guo Y, Williamson JE, and Chung P. Evaluation of outcomes in patients treated with antistaphylococcal penicillins versus cephalosporins in methicillin-susceptible Staphylococcus aureus bacteremia. Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), New Orleans, LA.

Nori P, Slinchenkova O, Porrovecchio A, Williamson J, Kumar A, Corpuz M, Dharmarajan TS, and Ostrowsky B. Engaging internists to champion antimicrobial stewardship on the wards. Presented at SHEA (Society for Healthcare Epidemiology of America) Spring 2015 Conference Orlando, FL.

Corpuz M, Nori P, Williamson JE, Boland-Reardon C, Denneny B, Adams A, Kolodner D, Suwandhi P, and Ostrowsky B. Challenges in an influenza outbreak in a psychiatry unit. Presented at SHEA (Society for Healthcare Epidemiology of America) Spring 2015 Conference Orlando, FL

Khan S, Williamson J, and Corpuz M. Changing the culture: Spreading the stewardship message
to a new campus.  Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), Philadelphia PA.

Gandham S, Corpuz MO, Williamson JE, and Coyle C. Fulminant and fatal: Two strongyloidiasis cases in HTLV-1 patients.  Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), Philadelphia PA.

Park C, Szymczak W, Munjal I, Levi M, Gialanella P, Guo Y, Williamson JE, Chung P, Ruiz R, Nori P, and Ostrowsky B.  Lessons learned from early implementation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with antimicrobial stewardship, a pilot study. Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), Philadelphia PA.

Williamson JE, Sautter RL, Norton HJ, and McCurdy LH. Impact of standard microbiologic messaging on treatment duration and rate of infectious diseases consultation in Staphylococcus aureus bacteremia. Presented at ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America), San Diego, CA.

Hanna E, Passaretti CL, Horton JM, Williamson JE, Martini JB, Iannitti DA, and Sindram D.  Multidrug resistant gram negative rod (MDR GNR) infection hinders outcome improvements in severe infected necrotizing pancreatitis.  Presented ID Week (Joint Meeting of The Infectious Diseases Society of America and The Society of Healthcare Epidemiology of America, San Diego, CA

Quality Awards

Boger MS, Davidson L, Jaffa R, Kiliany R, Shah E, Morris L, Heniford BT.  Improving Documentation and Assessment of Beta-Lactam Allergies with Implementation of a Beta-Lactam Allergy Questionnaire and Assessment (Risk Stratification Tool) in Epic.  Silver Touchstone Award at Atrium Health’s 13th Annual Quality and Patient Experience Sharing Day. Charlotte, NC. August 2019.

Roshdy D., Isip J., Hammer K., Jaffa R., Leonard M., Gajurel K., Shahid Z., Polk C. “Impact of a Novel Pharmacy Service on Antimicrobial Utilization and Mediation-Related Errors in Immunocompromised Patient Populations.” Bronze Touchstone Award at Atrium Health’s 10th Annual Quality and Patient Experience Sharing Day. Charlotte, NC. August 2019.

Isip J., Davidson L., Medaris L., McCurdy, L., Fischer, K., Onsrud, J. “Antimicrobial Stewardship Implementation of Staphylococcus aureus Bacteremia Bundle at Large Multi-hospital Health System.” Poster presented at Atrium Health’s 9th Annual Quality and Patient Experience Sharing Day. Charlotte, NC. June 2018.

Close